Treatment With Aspirin After Preeclampsia: TAP Trial

Recruiting Phase 4 Interventional Study
Hypertensive Disorder of Pregnancy Pre-Eclampsia Hypertension Eclampsia Gestational Hypertension Cardiovascular Diseases Toxemia Pregnancy Complications Vascular Diseases Hypertension, Pregnancy Induced Hypertension;Pre-Eclamptic
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 55
Sex
Female
Trial phase
Phase 4
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
Malamo Countouris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period after preeclampsia through two specific aims: 1) to pilot test the feasibility of conducting a randomized controlled trial of postpartum low dose aspirin vs. placebo, and 2) to assess the effect of po…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Postpartum individuals ≥18 years old * Preeclampsia diagnosis Exclusion Criteria: * Fetal anomaly * Multiple gestation * Pre-pregnancy hypertension * Allergy or contraindication to low-dose aspirin * Pre-pregnancy diabetes
Contacts

Alisse K Hauspurg, MD

412-641-1381

janickia@upmc.edu

CONTACT

Sila Yavan, MS

4124174981

yavans@upmc.edu

CONTACT